CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer
出版年份 2020 全文链接
标题
CXCL12/CXCR4 Axis-Targeted Dual-Functional Nano-Drug Delivery System Against Ovarian Cancer
作者
关键词
-
出版物
International Journal of Nanomedicine
Volume Volume 15, Issue -, Pages 5701-5718
出版商
Informa UK Limited
发表日期
2020-08-07
DOI
10.2147/ijn.s257527
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Safety and Efficacy of Low-dose Nanoparticle Albumin-bound Paclitaxel for HER2-negative Metastatic Breast Cancer
- (2018) ANTICANCER RESEARCH
- The CXCL12/CXCR4 axis promotes migration, invasion and EMT in human papillary thyroid carcinoma B-CPAP cells via NF-κB signaling
- (2018) Yuanqiang Lin et al. Biochemistry and Cell Biology
- Overcoming obstacles in the tumor microenvironment: Recent advancements in nanoparticle delivery for cancer theranostics
- (2018) Marta Overchuk et al. BIOMATERIALS
- Naringin enhances endothelial progenitor cell (EPC) proliferation and tube formation capacity through the CXCL12/CXCR4/PI3K/Akt signaling pathway
- (2018) Zhihu Zhao et al. CHEMICO-BIOLOGICAL INTERACTIONS
- Epithelial-to-mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity
- (2018) Deli Hong et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Role of CXCL12-CXCR4 axis in ovarian cancer metastasis and CXCL12-CXCR4 blockade with AMD3100 suppresses tumor cell migration and invasion in vitro
- (2018) Yan Liu et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Transformative hyaluronic acid-based active targeting supramolecular nanoplatform improve long circulation and enhance cellular uptake in cancer therapy
- (2018) Lu Zhong et al. Acta Pharmaceutica Sinica B
- Targeting the CXCR4/CXCL12 axis in treating epithelial ovarian cancer
- (2017) T L Mao et al. GENE THERAPY
- Path toward Precision Oncology: Review of Targeted Therapy Studies and Tools to Aid in Defining “Actionability” of a Molecular Lesion and Patient Management Support
- (2017) Young Kwang Chae et al. MOLECULAR CANCER THERAPEUTICS
- Abortifacient metapristone (RU486 derivative) interrupts CXCL12/CXCR4 axis for ovarian metastatic chemoprevention
- (2017) Ning Zheng et al. MOLECULAR CARCINOGENESIS
- RGD-Modified Albumin Nanoconjugates for Targeted Delivery of a Porphyrin Photosensitizer
- (2017) Fang Li et al. MOLECULAR PHARMACEUTICS
- Chemotherapy induces adaptive drug resistance and metastatic potentials via phenotypic CXCR4-expressing cell state transition in ovarian cancer
- (2017) Hyun Hee Lee et al. PLoS One
- Finding New Tricks for Old Drugs: Tumoricidal Activity of Non-Traditional Antitumor Drugs
- (2016) Fangrong Zhang et al. AAPS PHARMSCITECH
- Targeted silencing of CXCR4 inhibits epithelial-mesenchymal transition in oral squamous cell carcinoma
- (2016) Yuansheng Duan et al. Oncology Letters
- Nano-assembly of bovine serum albumin driven by rare-earth-ion (Gd) biomineralization for highly efficient photodynamic therapy and tumor imaging
- (2016) Ya Wen et al. Journal of Materials Chemistry B
- Targeted and effective photodynamic therapy for cancer using functionalized nanomaterials
- (2016) Eun Ji Hong et al. Acta Pharmaceutica Sinica B
- Does ligand–receptor mediated competitive effect or penetrating effect of iRGD peptide when co-administration with iRGD-modified SSL?
- (2015) Wei-Qiang Zhang et al. JOURNAL OF DRUG TARGETING
- CXCL12-CXCR4 Axis Promotes Proliferation, Migration, Invasion, and Metastasis of Ovarian Cancer
- (2015) Qing Guo et al. ONCOLOGY RESEARCH
- Design, optimization and in-vitro study of folic acid conjugated-chitosan functionalized PLGA nanoparticle for delivery of bicalutamide in prostate cancer
- (2015) Namdev L. Dhas et al. POWDER TECHNOLOGY
- Noninvasive Imaging Reveals Inhibition of Ovarian Cancer by Targeting CXCL12-CXCR4
- (2015) Paramita Ray et al. NEOPLASIA
- CXCR4 inhibition enhances radiosensitivity, while inducing cancer cell mobilization in a prostate cancer mouse model
- (2014) Urszula M. Domanska et al. CLINICAL & EXPERIMENTAL METASTASIS
- CXCL12/CXCR4 Blockade by Oncolytic Virotherapy Inhibits Ovarian Cancer Growth by Decreasing Immunosuppression and Targeting Cancer-Initiating Cells
- (2014) Margaret Gil et al. JOURNAL OF IMMUNOLOGY
- The SDF-1/CXCR4 axis induces epithelial–mesenchymal transition in hepatocellular carcinoma
- (2014) Xuqi Li et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Molecular mechanisms of epithelial–mesenchymal transition
- (2014) Samy Lamouille et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Polymeric Plerixafor: Effect of PEGylation on CXCR4 Antagonism, Cancer Cell Invasion, and DNA Transfection
- (2014) Yan Wang et al. PHARMACEUTICAL RESEARCH
- Epithelial-to-mesenchymal transition: What is the impact on breast cancer stem cells and drug resistance
- (2013) Paraskevi Mallini et al. CANCER TREATMENT REVIEWS
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- SDF-1/CXCR4 signaling induces pancreatic cancer cell invasion and epithelial–mesenchymal transition in vitro through non-canonical activation of Hedgehog pathway
- (2012) Xuqi Li et al. CANCER LETTERS
- Design of a Cellular-Uptake-Shielding “Plug and Play” Template for Photo Controllable Drug Release
- (2011) Wang Xiao et al. ADVANCED MATERIALS
- CXCL12/CXCR4 Blockade Induces Multimodal Antitumor Effects That Prolong Survival in an Immunocompetent Mouse Model of Ovarian Cancer
- (2011) E. Righi et al. CANCER RESEARCH
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now